HB 652 Summary

• Amends Ohio's drug control laws to add definitions for "benzodiazepine" and "opioid analgesic" controlled substances, with opioid analgesics including drugs like fentanyl, hydrocodone, oxycodone, morphine, and tramadol.

• Requires pharmacists dispensing opioid analgesics for 5+ days to discuss addiction risks with patients and may charge a fee; establishes board of pharmacy rules for red warning labels on opioid containers describing addiction and overdose risks.

• Mandates prescribers (physicians, dentists, advanced practice nurses, physician assistants) check the Ohio Automated Rx Reporting System (OARRS) drug database before prescribing opioids or benzodiazepines, with periodic rechecks every 90 days for ongoing treatment.

• Removes "tramadol products" language from chronic pain treatment provisions, clarifying that physicians' authority covers only controlled substances (not tramadol products) for chronic pain management.

• Authorizes a cash transfer from the Medical Marijuana Control Program Fund to the Drug Database Fund to support OARRS operations and drug diversion reduction initiatives.